Integrum AB (publ) (STO: INTEG.B)

Market Cap	612.94M
Revenue	110.46M
Net Income	4.17M
Shares Out	19.40M
EPS	0.22
PE Ratio	143.64
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	365,060
Open	33.00
Previous Close	32.00
Day's Range	30.00 - 33.50
52-Week Range	17.12 - 64.00
Beta	1.75
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 4, 2024

About Integrum AB

Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. The company also provides Neuromotus, a technology that is used for therapy to reduce phantom ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1962
• Employees: 36
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: INTEG.B